The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 18, 2020

Filed:

Sep. 15, 2017
Applicant:

Mannkind Corporation, Westlake Village, CA (US);

Inventors:

Chad C. Smutney, Watertown, CT (US);

Benoit Adamo, South Salem, NY (US);

Brendan F. Laurenzi, Middlebury, CT (US);

P. Spencer Kinsey, Sandy Hook, CT (US);

Assignee:

MannKind Corporation, Westlake Village, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 15/00 (2006.01); A61M 11/00 (2006.01); A61M 16/00 (2006.01);
U.S. Cl.
CPC ...
A61M 15/00 (2013.01); A61M 11/001 (2014.02); A61M 15/002 (2014.02); A61M 15/0005 (2014.02); A61M 15/0021 (2014.02); A61M 15/0028 (2013.01); A61M 15/0025 (2014.02); A61M 15/0065 (2013.01); A61M 2016/0027 (2013.01); A61M 2202/064 (2013.01); A61M 2205/076 (2013.01); A61M 2206/14 (2013.01); A61M 2206/16 (2013.01); A61M 2206/20 (2013.01);
Abstract

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, with or without a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, hormones such as insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, diseases and disorders, including endocrine disease such as diabetes and/or obesity.


Find Patent Forward Citations

Loading…